VICINIVAX

ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines... ViciniVax' product candidate Vvax001 is a recombinant viral vector, specifically modified to elicit a strong immunological anti-tumor response after vaccination. We demonstrated in mice that Vvax001 induces robust HPV-specific cellular immune and memory responses, resulting in excellent therapeutic anti-tumor efficacy.

Also known as: ViciniVax BV

Registration numbers: 01136472 (W)

VAT numbers: NL8198.45.681.B01

Primary location: Groningen Netherlands